A new study unveiled a groundbreaking approach to predicting the effectiveness of treatments for patients with Diffuse Large B-Cell Lymphoma (DLBCL), a common form of blood cancer.
Personalized simulations predict patient outcomes for blood cancer treatment
- Post author:
- Post published:July 16, 2024
- Post category:News Feed
- Post comments:0 Comments